S&P 500 Industrials Sector SEC Filings — April 21, 2026

21-04-2026

Tarsier Pharma Ltd., an Israel-based emerging growth company and foreign private issuer in the pharmaceutical sector (SIC 2834), filed a Form F-1 registration statement on April 21, 2026, for an initial public offering of ordinary shares (par value NIS 0.01) on the NYSE American under the symbol 'TARX', with pricing anticipated between blank placeholders and underwritten by Konik Capital Partners. The clinical-stage biopharma is developing TRS01 (pivotal Phase 3 trial planned under FDA SPA for uveitis/uveitic glaucoma) and TRS02 (slow-release injectable for retinal diseases) based on novel dazdotuftide, targeting ~615,000 US patients with anterior non-infectious uveitis (~160,000 progressed to uveitic glaucoma). No financial performance metrics or period comparisons are provided in the filing excerpt; the company reports under US GAAP with functional currency USD and NIS 3.19/$1.00 exchange rate as of Dec 31, 2025.

• ·Fiscal year end: December 31
• ·Exchange rate used: NIS 3.19 = $1.00 (as of December 31, 2025)
• ·SEC file number: 333-295210
• ·Central Index Key: 0002102720
• ·Business address: 10 HaMa’apilim St., Zichron Yaacov, Israel 3093765

21-04-2026

First Guaranty Bancshares, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Shareholders on May 21, 2026, at 2:00 p.m. local time in Hammond, Louisiana, to elect seven directors, approve an advisory non-binding resolution on executive compensation, and ratify EisnerAmper, LLP as the independent registered public accounting firm for the year ending December 31, 2026. The record date is March 30, 2026, with 15,793,433 shares of $1 par value common stock outstanding, each entitled to one vote; preferred stock does not vote. No other financial metrics or period comparisons are provided in the filing.

• ·Meeting quorum requires presence of holders of a majority of outstanding common shares.
• ·Directors elected by plurality vote; advisory vote on executive compensation and auditor ratification each require majority of shares cast.
• ·Proxy materials first mailed on or about April 21, 2026; virtual attendance options provided via website and phone.
• ·Board nominees include Marshall T. Reynolds (age 89, Director since 1993), Jack Rossi (age 81, since 2018), Edgar R. Smith III (age 62, since 2007), and Vanessa R. Drew (age 70, since 2022).

21-04-2026

Pinnacle Wealth Management Advisory Group, LLC filed its 13F-HR on April 21, 2026, reporting equity holdings as of March 31, 2026, with no prior period comparisons provided in the filing. Top positions include Apple Inc at $55162650 (217355 shares sole discretion), Invesco QQQ Trust Series I ETF at $37945928 (65744 shares sole), Alphabet Inc Cap Cl A at $24144111 (83962 shares sole), Broadcom Inc at $19230431 (62132 shares sole), and Amazon.Com Inc at $16554022 (79483 shares sole). The diversified portfolio spans technology leaders, ETFs, healthcare, and financials, with several smaller positions at $0 value but non-zero shares indicating potential liquidations or valuation issues.

• ·Several positions show split voting authority, e.g., American Express Co (23994 total shares: 23044 sole voting, 950 other voting)
• ·Amgen Inc (13876 total shares: 13836 sole voting, 40 other voting)
• ·Positions with $0 market value but shares outstanding include Hemp Inc (25000 shares, all other voting), Global Security & Intelligence (10000 shares), IDdriven Inc (10000 shares), Innovet Inc (32500 shares), Intl Meta Sys Inc (37000 shares)

21-04-2026

Peoples Bancorp Inc. reported net income of $29.0 million ($0.81 diluted EPS) for Q1 2026, down from $31.8 million ($0.89 EPS) in Q4 2025 but up from $24.3 million ($0.68 EPS) in Q1 2025. Net interest margin improved to 4.16% from 4.12% QoQ and the prior year, driven by lower deposit costs, with asset quality enhancing as net charge-offs fell to 0.40% from 0.44% QoQ and nonperforming assets declined to 0.59%. However, net interest income decreased $0.6 million QoQ due to lower accretion income and fewer days, provision for credit losses rose to $9.7 million from $8.1 million QoQ, and efficiency ratio increased slightly to 58.6% from 57.8%.

• ·Core deposits increased $191.8 million QoQ due to strategic reduction in brokered CDs.
• ·Criticized loans decreased $12.3 million (5%) QoQ.
• ·Available-for-sale investment securities unrealized losses, net of tax: $76.4 million at March 31, 2026.
• ·Commercial and industrial loans increased $111.0 million QoQ but construction loans decreased $31.4 million QoQ.
• ·Income tax expense $8.3 million at 22.3% effective rate Q1 2026.

21-04-2026

Tractor Supply Company reported first quarter 2026 net sales increased 3.6% YoY to $3.59 billion, with comparable store sales up 0.5% driven by new store openings, strength in four of five product categories, and double-digit digital sales growth. However, operating income declined 6.3% to $233.4 million, net income fell 8.3% to $164.5 million, and diluted EPS decreased 7.2% to $0.31, due to higher SG&A expenses as a percentage of sales and companion animal category underperformance. The company opened 40 new Tractor Supply stores, repurchased shares for $118.0 million, and reaffirmed its FY2026 outlook including comparable store sales growth of 1% to 3% and diluted EPS of $2.13 to $2.23.

• ·Opened 40 new Tractor Supply stores and closed 1 Petsense store in Q1 2026.
• ·Gross margin flat at 36.2% YoY, impacted by higher tariffs and transportation costs.
• ·SG&A expenses as % of net sales increased 70 basis points to 29.7%.
• ·Inventory increased to $3,583,601 thousand from $3,213,885 thousand YoY.
• ·FY2026 guidance: Net sales +4% to +6%, operating margin 9.3% to 9.6%, net income $1.11B to $1.17B.

21-04-2026

Genuine Parts Company reported Q1 2026 sales of $6.3 billion, up 6.8% YoY from $5.9 billion, driven by comparable sales growth of 2.4%, acquisitions, and favorable FX, with strong performances in International Automotive (+13.2%) and Industrial (+5.2%) segments. However, GAAP net income declined to $189 million ($1.37 diluted EPS) from $194 million ($1.40), and International Automotive EBITDA margin fell 80 basis points to 9.1% despite sales growth. Adjusted net income rose slightly to $245 million ($1.77 EPS) from $243 million ($1.75), excluding restructuring and separation costs; the company reaffirmed full-year 2026 outlook and noted progress on separating Automotive and Industrial businesses by Q1 2027.

• ·Free cash flow deficit of $34 million in Q1 2026 due to seasonal factors and investments.
• ·Full-year 2026 outlook: Total sales growth 3% to 5.5%; Adjusted diluted EPS $7.50 to $8.00; Free cash flow $550M to $700M.
• ·Restructuring and other costs: $57.7 million in Q1 2026 vs. $54.8 million prior year.
• ·Separation of businesses on track for completion in Q1 2027.

21-04-2026

Boxabl Inc. issued an investor presentation on April 21, 2026, for use in connection with its previously announced merger with FG Merger II Corp., pursuant to the August 4, 2025 Merger Agreement, positioning Boxabl as a solution to the U.S. housing crisis with foldable factory-built modules enabling national shipping and mass production. The presentation highlights cost advantages, including a 2,400 sq ft home at an estimated $213,551 ($88/sq ft) versus traditional construction at $355,757 ($134/sq ft), a 43% direct material cost reduction since 2022 baseline, and market opportunities with a $2.2T TAM, $36B SAM, and ~$1B SOM. Key milestones include 800+ homes built, $235MM crowdfunding raised, 35M+ website views in the last 12 months, and 5,000 pre-orders for its retail travel trailer product.

• ·Merger Agreement entered August 4, 2025; presentation dated April 21, 2026
• ·Factory milestones: 400,000 sq ft of factories; automated factory produces more volume with less labor vs. manual
• ·Deployed in 12 states (NV, CA, UT, OK, HI+); approved in 12 states (AK, CA, CT, DE, KS, NY, OK, OR, UT, VT, WV, WY)
• ·Retail product in tooling, anticipated 2027 launch; commercial tier one supplier collaborations; public sector for FEMA/military/workforce/homeless

21-04-2026

United Community Banks, Inc. reported Q1 2026 net income of $84.3 million, up 18% YoY from $71.4 million, with diluted EPS of $0.69, up 19% YoY, driven by 12% revenue growth to $276.5 million and NIM expansion to 3.65% (up 29 bps YoY), alongside loan growth of $218 million (4.5% annualized QoQ) and deposit growth of $237 million QoQ. However, net income declined slightly QoQ from $86.5 million, revenue dipped to $276.5 million from $278.4 million, noninterest expense rose 11% YoY, net charge-offs increased to $10.4 million (0.22% of avg loans, up from 0.21% YoY), and NPAs edged up to 0.35% of assets. The company also announced a definitive merger agreement to acquire Peach State Bancshares, Inc., repurchased 1.09 million shares at $33.97 average, and plans to redeem $100 million in subordinated debentures.

• ·Allowance for credit losses on loans at 1.15% coverage, down slightly from 1.16% at Dec 31, 2025.
• ·Common Equity Tier 1 ratio preliminary 13.4%.
• ·Mortgage closings $251M (up from $187M YoY); mortgage rate locks $408M (up from $330M YoY).
• ·Intent to redeem remaining $100M subordinated debentures in Q2 2026.
• ·Conference call scheduled for April 21, 2026 at 9:00 a.m. EST.

21-04-2026

BioMarin Pharmaceutical Inc. (BMRN) filed a DEFA14A Definitive Additional Materials proxy statement on April 21, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee is required and is submitted by the registrant. No substantive financial or operational details are provided in the cover page.

21-04-2026

Denali Therapeutics Inc. (DNLI) filed a DEFA14A Definitive Additional Materials proxy statement on April 21, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is classified as soliciting material under §240.14a-12. No specific financial data, voting items, or substantive proxy details are provided in the document header.

21-04-2026

Archimedes Tech SPAC Partners II Co. (ATII) entered into an Agreement and Plan of Merger on April 20, 2026, with Forge Nano, Inc., involving a reincorporation to Delaware as Forge Nano Holdings Inc., followed by two mergers to acquire Forge Nano for $1,200,000,000 in Closing Payment Shares at $10.00 per share. Forge Nano stockholders and convertible securities holders are eligible for up to 90,000,000 Earn-Out Shares over a 5-year period upon achieving stock price VWAP or revenue milestones of $400,000,000, $600,000,000, and $800,000,000. No current financial performance data is provided in the filing.

• ·ATII Warrants exercisable at $11.50 per share convert to Pubco Warrants on same terms.
• ·Forge Nano Options convert to Pubco Options adjusted by Applicable Per Share Merger Consideration and Equity Award Conversion Amount.
• ·Earn-Out Shares issued to Escrow at Closing and disbursed upon cumulative milestone achievement; convertible securities portion disbursed only upon exercise.
• ·Transaction includes Form S-4 registration statement with ATII proxy for shareholder approval.

21-04-2026

Battalion Oil Corporation filed an S-3 shelf registration statement on April 21, 2026, to enable future securities offerings, incorporating its 2025 10-K and recent 8-Ks. As of December 31, 2025, the company reported 59.7 MMBoe proved reserves (60% proved developed), average daily production of 12,096 Boe/d from Delaware Basin assets, and 39,968 net acres. Recent developments include the February 2026 closing of the $60.1 million West Quito Divestiture (reducing production by 15% and reserves by 10%) and a March 2026 private placement raising $15.0 million in gross proceeds.

• ·Reserves prepared using SEC-required pricing: WTI $66.01/Bbl, Henry Hub $3.39/MMBtu.
• ·Private placement shares priced at $5.50/share; pre-funded warrants at $5.4999/share with $0.0001 exercise price, expiring March 4, 2033.

21-04-2026

JATT II Acquisition Corp, a blank check SPAC targeting healthcare and biotechnology sectors, announced the pricing of its $60,000,000 initial public offering of 6,000,000 ordinary shares at $10.00 per share, expected to begin trading on Nasdaq under ticker 'JATT' on April 17, 2026, with closing on April 20, 2026. Guggenheim Securities, LLC serves as sole book-running manager, with a 45-day option for underwriters to purchase up to 900,000 additional shares for over-allotments. The SEC declared the registration statement effective on April 16, 2026.

• ·Company sponsored by JATT Ventures II L.P. and focused on healthcare, biotechnology, life sciences, with emphasis on data-driven approaches like machine learning and computational biology.
• ·SEC registration statement declared effective on April 16, 2026.
• ·No specific business combination target selected as of announcement.

21-04-2026

Provectus Biopharmaceuticals, Inc. announced via press release that its 2026 Annual Meeting of Stockholders will be held on June 18, 2026, at Perkins Place, its planned new headquarters in Knoxville, Tennessee. A preliminary proxy statement was filed with the SEC on April 20, 2026, with a record date of the same day, and proxy materials will be made available to stockholders.

• ·Preliminary proxy statement filed with SEC on April 20, 2026
• ·Record date for stockholders: April 20, 2026
• ·Annual Report on Form 10-K for year ended December 31, 2025, filed March 26, 2026

21-04-2026

MRWM Advisors, LLC filed its 13F-HR on April 21, 2026, for the quarter ended March 31, 2026, disclosing 74 equity holdings with a total market value of $184,447,846, all held with sole voting and disposition power. The portfolio is diversified across ETFs (e.g., Vanguard Total Stock Market ETF at $26,858,213) and large-cap stocks (e.g., Apple Inc. at $5,517,834). No shared power positions or other voting authority reported.

• ·Formerly known as Cypress Capital Advisors, LLC (name change February 28, 2018)
• ·Business address: 1614 16th Avenue South, Nashville, TN 37212
• ·No other managers or shared voting/disposition power reported

21-04-2026

Barron's article in this Form 425 filing highlights the 2026 resurgence of quantum computing companies going public via SPAC mergers, including Infleqtion (Feb), Horizon Quantum (Mar), and Xanadu Quantum Technologies (Mar 27) with shares surging 15% on debut, alongside upcoming deals like IQM with Real Asset Acquisition. It features positive comments from Pasqal CEO Wasiq Bokhari on Bleichroeder Acquisition Corp. II's proposed business combination with Pasqal Holding SAS for U.S. capital access, but warns of de-SPAC risks like high redemptions, average 60% stock price drops post-merger over five years, and quantum stocks' volatility with no profitability. IonQ achieved over $100M in annual GAAP revenue in 2025, yet investments remain speculative.

• ·IonQ 52-week trading range: $23.49 low to $84.64 high
• ·Rigetti 52-week trading range: below $8 to above $58
• ·Quantinuum filed confidentially for IPO, potentially as soon as 2026
• ·No quantum de-SPACs in 2025
• ·Citi initiated Infleqtion at Buy; Northland initiated Xanadu at Outperform

21-04-2026

Tumwater Wealth Management, LLC filed its 13F-HR report on April 21, 2026, disclosing total holdings of $248,641,449 across 34 positions as of March 31, 2026. The portfolio is dominated by Dimensional ETF Trust products, including World ex US Core Equity ETF ($72,974,014, 2,148,190 shares), US Targeted Value ETF ($39,264,501, 628,735 shares), and US Large Cap Value ETF ($31,956,843, 894,899 shares), alongside Vanguard ETFs like Total Stock Market ETF ($52,762,979, 164,468 shares). Individual stock positions include Apple Inc ($1,101,530, 4,340 shares) and Chevron Corporation ($2,933,251, 14,177 shares), with all holdings reported as sole discretionary.

• ·Report filed as of April 21, 2026; period end March 31, 2026
• ·All 34 positions held as sole discretionary (SH SOLE) with zero put/call options
• ·Headquartered at 110 W Main St, Boise, ID 83702

21-04-2026

Decker Retirement Planning Inc. reported total holdings valued at $220,723,730 across 284 positions as of March 31, 2026, in its 13F-HR filing submitted April 21, 2026. The portfolio emphasizes ETFs, with the largest position in iShares 0-3 Month Treasury ETF at $38,607,255 (18% of total), followed by Invesco Solar ETF ($9,745,295) and J.P. Morgan Equity Premium Income ETF ($8,021,024). All reported holdings are held with sole voting power, reflecting a diversified mix of fixed income, equity, and thematic investments including semiconductors like Photronics Inc. ($3,935,328).

• ·Filing Date: April 21, 2026
• ·Report Period End: March 31, 2026
• ·CIK: 0001975700
• ·Business Address: 2889 W. Ashton Blvd. Suite 125, Lehi, UT 84043
• ·Business Phone: 855-425-4566
• ·All holdings reported with sole investment discretion and voting power

21-04-2026

Delek US Holdings, Inc. announced the appointment of Amber Russell as Executive Vice President, Refining, effective April 20, 2026, succeeding Joseph Israel, who is departing after contributions to operational excellence. Ms. Russell brings nearly three decades of experience from ExxonMobil and bp, including senior roles in refining, terminals, and pipelines. Avigal Soreq, President and CEO, highlighted her expertise as key to strengthening Delek's refining platform.

• ·Ms. Russell will be based at Delek’s Brentwood, Tennessee office and report directly to Avigal Soreq.
• ·Announcement dated April 20, 2026; SEC filing April 21, 2026.

21-04-2026

Opus Genetics, Inc. filed an S-3/A amendment to register for resale up to 7,374,632 shares of common stock by selling stockholders, issuable upon automatic conversion of an equal number of Series B Non-Voting Convertible Preferred Stock from a private placement that closed on February 18, 2026, at $3.39 per share. The company will not receive proceeds from these resales, which are intended to satisfy registration rights obligations. Common stock trades on Nasdaq under 'IRD' with a last reported sale price of $5.75 on April 17, 2026.

• ·Private Placement securities purchase agreement entered February 13, 2026; stockholder approval obtained for authorized common shares increase to permit conversion.
• ·Series B Preferred Stock converts automatically on or about April 23, 2026, subject to beneficial ownership limitations.
• ·Registrant classified as non-accelerated filer and smaller reporting company.
• ·Principal executive offices: 8 Davis Drive, Suite 220, Durham, NC 27713; phone (248) 957-9024.

21-04-2026

Independent Wealth Network Inc. (CIK: 0001891240) filed a 13F-HR on April 21, 2026, disclosing $336706849 in total holdings as of March 31, 2026, across 301 positions, all held on a sole discretionary basis. Top holdings include Caterpillar Inc. at $18503350 (26118 shares), JPMorgan Exchange-Traded F Ultra Shrt ETF at $12648282 (249917 shares), and iShares Silver Tr Ishares at $7207686 (105778 shares). This filing provides a snapshot of portfolio composition with no period-over-period changes reported.

• ·Business address: 2350 NW 128TH ST., URBANDALE, IA 50323
• ·Phone: 515-461-5123
• ·SEC file number: 028-21395
• ·All holdings reported as SH SOLE with 0 SH PRN, 0 SH SHRD, 0 OTHER

21-04-2026

Prelude Therapeutics Incorporated (Nasdaq: PRLD) announced the pricing of an underwritten public offering of 18,018,014 shares of common stock at $4.44 per share and pre-funded warrants to purchase up to 2,252,252 shares at $4.4399 per warrant, expecting gross proceeds of approximately $90.0 million before expenses. The offering, led by new investor RA Capital Management with participation from Soleus Capital and others, is anticipated to close on or about April 21, 2026, with net proceeds allocated to general corporate purposes including research, preclinical, and clinical development of product candidates. No declines or flat metrics were reported in this financing announcement.

• ·Registration statement on Form S-3 filed with SEC on May 30, 2024, declared effective June 10, 2024.
• ·Offering joint book-running managers: Goldman Sachs & Co. LLC, Evercore ISI, Citizens Capital Markets.

21-04-2026

Coronado Global Resources Inc. filed an 8-K under Regulation FD Disclosure, announcing that it lodged an ASX announcement on April 20, 2026, regarding an upcoming investor conference call on April 27, 2026 (April 28, 2026 in Australia). The announcement is attached as Exhibit 99.1, with direct call link details provided. No financial or operational metrics were disclosed.

• ·Direct link to conference call: https://s1.c-conf.com/diamondpass/10053845-e8cjhi.html
• ·Filing date: April 21, 2026; Earliest event date: April 20, 2026

21-04-2026

Grey Ledge Advisors, LLC disclosed total holdings of $442,992,213 across 239 securities in its 13F-HR filing as of March 31, 2026. The portfolio is diversified with significant allocations to ETFs such as Harbor International Compounders ETF ($11,158,009) and PIMCO Multisector Bond Active Exchange-Traded Fund ($12,347,591), alongside individual stocks like Apple Inc. and NVIDIA Corporation. No prior period comparisons or changes are provided in this routine quarterly snapshot.

• ·Filing date: April 21, 2026
• ·Report period end: March 31, 2026
• ·All reported holdings held with sole voting and dispositive power

21-04-2026

Up Capital Management, Inc. disclosed total holdings of $89,148,360 across 18 positions in its 13F-HR filing as of March 31, 2026. The portfolio features significant allocations to technology stocks and ETFs, with top holdings NVIDIA Corporation ($25,259,137), Vanguard S&P 500 ETF ($12,663,707), and Invesco QQQ Trust ($7,827,915). No period-over-period changes are provided in the filing.

• ·Filing period end date: March 31, 2026
• ·Filing date: April 21, 2026
• ·All holdings reported as sole voting authority (SH SOLE)

21-04-2026

Pegasus Asset Management, Inc. disclosed total holdings of $312,758,568 across 67 positions in its 13F-HR filing as of March 31, 2026, with all positions held under sole voting power. Top holdings by value include Schwab Strategic Tr US Brd Mkt ETF ($29,132,052), Apple Inc ($20,885,019), Alphabet Inc Cap Stk Cl C ($16,965,188), NVIDIA Corp ($14,230,737), and Microsoft Corp ($13,479,371). The report was filed on April 21, 2026.

• ·All holdings reported with sole voting power (SH SOLE) and no shared or other voting power.
• ·Date as of change: 04-20-2026
• ·Business address: 44 Whippany Road, Suite 101, Morristown, NJ 07960

21-04-2026

Randall & Associates Wealth Management filed a 13F-HR report disclosing 56 equity positions with a total market value of $148368433 as of March 31, 2026, all held on a sole discretionary basis. The filing, signed by Collin Randall (CCO), reflects no put/call positions or other voting authority. The firm, formerly known as Bennett Associates Wealth Management (name change effective February 13, 2024), manages these holdings from its office in Butler, PA.

• ·Filing date: April 21, 2026
• ·Report period end: March 31, 2026
• ·Business address: 122 South Washington Street, Butler, PA 16001
• ·SEC file number: 028-23862
• ·All positions held as SOLE with no shared voting or put/call activity

21-04-2026

Tanglewood Wealth Management, Inc. (CIK: 0001454308) filed its 13F-HR on April 21, 2026, disclosing $1207340732 in total holdings across 38 positions as of March 31, 2026. The portfolio emphasizes fixed income and international ETFs, with top holdings including iShares 3-7 Year Treasury Bond ETF ($189383043, 1596822 shares sole), Vanguard FTSE Developed Markets ETF ($186705782, 2913636 shares sole), and iShares 1-3 Year Treasury Bond ETF ($76981910, 932323 shares sole). Other positions include individual stocks such as Apple Inc. (2160 shares, $548186), Microsoft Corp. (1134 shares, $419773), and Berkshire Hathaway Inc. Del Cl A (1 share, $718140).

• ·SEC file number: 028-13327
• ·Adviser ID: 107639
• ·Business address: 1400 Post Oak Blvd, Suite 800, Houston, TX 77056
• ·All holdings reported as sole discretion with zero shared or other voting authority
• ·Berkshire Hathaway Inc. Del Cl A held at 1 share

21-04-2026

Columbia Asset Management filed its 13F-HR on April 21, 2026, disclosing institutional holdings as of March 31, 2026, consisting of 170 positions with a total market value of $525,088,903, all held with sole voting power. Top holdings by value include Apple Inc. ($50,272,875 for 198,088 shares), Microsoft Corp. ($33,354,285 for 90,105 shares), Alphabet Inc. CAP STK CL A ($21,302,726 for 74,081 shares), and Amazon.com Inc. ($17,596,603 for 84,489 shares). No prior period comparisons or performance metrics are provided in this snapshot filing.

• ·All 170 positions held with sole voting power (SH SOLE) and no shared or other voting power indicated.
• ·Filing managed under investment adviser ID 801-62115.
• ·Business address: 924 North Main Street, Suite 1, Ann Arbor, MI 48104.

21-04-2026

PennyMac Mortgage Investment Trust's 2026 Proxy Statement seeks shareholder approval for the election of three Class II trustees (Preston DuFauchard, Nancy McAllister, and Stacey D. Stewart), ratification of the independent registered public accounting firm for the fiscal year ending December 31, 2026, and an advisory vote to approve executive compensation. The document highlights strong corporate governance features, including 78% independent trustees, robust share ownership guidelines (5x base retainer for non-management trustees, $2 million for CEO, $500,000 for other executives), shareholder rights to amend bylaws, and board refreshment with five new trustees added since 2021. It references 2025 business performance and shareholder returns outperforming indices as detailed in the Form 10-K filed February 18, 2026, with no declines noted in the provided content.

• ·2026 Annual Meeting: Tuesday, June 16, 2026, at 11:00 a.m. Pacific Time, online at www.virtualshareholdermeeting.com/PMT2026.
• ·Record Date: April 20, 2026.
• ·Mail Date: April 21, 2026.
• ·Preston DuFauchard elected Independent Lead Trustee on March 19, 2024, for a three-year term.
• ·Shareholder right to amend bylaws: majority vote by group of up to five shareholders holding at least 1% of common shares for one year.
• ·Trustee limits: CEO limited to two outside public boards; others to five.
• ·2025 Form 10-K filed February 18, 2026.

21-04-2026

Danaher reported first quarter 2026 revenues of $6.0 billion, up 3.5% year-over-year, though non-GAAP core revenue growth was modest at 0.5% reflecting strength in Bioprocessing and Life Sciences offset by a lighter-than-typical respiratory season at Cepheid. Non-GAAP adjusted diluted EPS grew 9.5% to $2.06, with net earnings of $1.0 billion, operating cash flow of $1.3 billion, and non-GAAP free cash flow of $1.1 billion. The company announced its intention to acquire Masimo Corporation and raised full-year 2026 adjusted diluted EPS guidance to $8.35 to $8.55 from $8.35 to $8.50.

• ·Full year 2026 non-GAAP core revenue expected to increase 3% to 6% YoY.
• ·Q2 2026 non-GAAP core revenue anticipated to increase low-single digit percent YoY.
• ·Estimated amortization of acquisition-related intangible assets of $1.7 billion for FY 2026.
• ·Approximately 60,000 associates worldwide.

21-04-2026

Faraday Future received full $45 million in low-cost, low-dilution financing from a U.S. institutional investor, with $15 million immediately available to accelerate EAI robotics and FX Super One deliveries, and approximately 120 million shares reserved for potential future conversion. The proxy seeks stockholder approval for a 45% increase in authorized shares (~140 million additional) and a reverse stock split as a precautionary measure for Nasdaq listing compliance, while new executive directors Jerry Wang and Lucky Jiang join the board amid management restructuring. This funding follows the closure of an SEC investigation without action, signaling capital market recognition, though Nasdaq compliance and dilution risks persist.

• ·Notes not redeemable until at least six months after closing.
• ·EAI Developer Ecosystem Forum and FF EAI Robotics platform launch scheduled for April 25, 2026, in San Francisco Bay Area.
• ·SEC investigation closed with no enforcement action less than one month prior.

21-04-2026

Compass Wealth Management LLC filed its 13F-HR report on April 21, 2026, disclosing 75 sole discretionary equity holdings as of March 31, 2026. The portfolio features significant positions in technology and ETFs, including Broadcom Inc. ($25,484,435 market value, 82,338 shares) and Invesco S&P 500 Equal Weight ETF ($22,428,539 market value, 116,864 shares). Other notable holdings include Applied Materials Inc. ($13,039,973), Alphabet Inc. Class C ($12,880,014), and Alphabet Inc. Class A ($11,342,805), with no reported changes, additions, or reductions as this appears to be an initial filing.

• ·All 75 holdings reported with sole investment discretion and sole voting power (0 shared, 0 none).
• ·No put/call options or other managers listed.
• ·Firm address: 10 Water Street, Guilford, CT 06437.
• ·Central Index Key: 0001965653; SEC File Number: 028-23129.

21-04-2026

Edge Wealth Management LLC filed its 13F-HR on April 21, 2026, disclosing $584,870,903 in total holdings value as of March 31, 2026, across 85 positions all held with sole discretionary voting authority. Top holdings include Alphabet Inc. Cap Stk Cl A ($46,232,353), Apple Inc. ($42,056,911), Microsoft Corp. ($29,073,806), Walmart Inc. ($25,912,419), and JPMorgan Chase & Co. ($25,683,757). The portfolio features a diversified mix of equities, ETFs, and sectors including technology, financials, and energy.

• ·Filing covers period ending March 31, 2026
• ·All positions reported as SH SOLE (sole discretionary voting authority)
• ·Signed by N. Ashley Ramdass on April 20, 2026

21-04-2026

Pathfinder Wealth Consulting, Inc. disclosed 163 equity holdings totaling $154,300,029 as of March 31, 2026, all with sole investment discretion and voting authority. Largest positions include Vanguard Growth ETF ($8,816,369), Vanguard Value ETF ($8,713,342), Apple Inc. ($6,021,704), and Microsoft Corp. ($4,948,138). No shared discretion or other managers reported.

• ·Filing date: April 21, 2026
• ·Report period end: March 31, 2026
• ·All holdings reported as SOLE discretion with no voting authority shared
• ·Business address: 4018 Oleander Drive Suite 102, Wilmington, NC 28403

21-04-2026

Generali Investments Towarzystwo Funduszy Inwestycyjnych filed its 13F-HR on April 21, 2026, disclosing 146 equity holdings as of March 31, 2026, with a total portfolio value of $193731471, all held as sole discretionary positions with no reported changes, puts, or calls. Top holdings are concentrated in technology and growth stocks, including Microsoft Corp at $11251377 (30300 shares), NVIDIA Corporation at $10376800 (59500 shares), and HubSpot Inc at $3637090 (14900 shares). The filing provides a static snapshot with no period-over-period comparisons available.

• ·All 146 positions held as SOLE with 0 shared, 0 other managers, 0 puts, and 0 calls.
• ·SEC file number: 028-24764.
• ·Business address: UL SENATORSKA 18, WARSAW R9 00-082.

21-04-2026

Generali Powszechne Towarzystwo Emerytalne filed its 13F-HR report on April 21, 2026, for the period ending March 31, 2026, disclosing holdings in 28 securities totaling $565,568,900, all with sole voting authority. Largest positions include FREEPORT MCMORAN INC CL B ($52,443,516, 892,200 shares), CONOCOPHILLIPS ($42,570,000, 322,500 shares), and MICROSOFT CORP ($40,903,785, 110,500 shares). Other significant holdings feature NVIDIA CORPORATION ($29,648,000, 170,000 shares) and AMAZON COM INC ($33,948,010, 163,000 shares).

• ·Report filed under SEC file number 028-24761
• ·Business address: UL SENATORSKA 18, WARSAW R9 00-082
• ·Phone: 48888183503

21-04-2026

GE Aerospace reported strong Q1 2026 results with total orders surging 87% to $23.0B, GAAP revenue up 25% to $12.4B, and adjusted revenue growing 29% to $11.6B, driven by 34% growth in Commercial Engines & Services (CES) revenue and 19% in Defense & Propulsion Technologies (DPT). However, GAAP profit declined 2% to $2.2B with profit margin contracting 490 bps to 17.7%, operating profit margin down 200 bps to 21.8% despite 18% operating profit growth, and CES/DPT margins declining 230 bps and 20 bps respectively. The company maintained full-year 2026 guidance across key metrics like adjusted revenue growth of +21%, operating profit $9.85B-$10.25B, adjusted EPS $7.10-$7.40, and FCF $8.0B-$8.4B, trending toward the high-end.

• ·CES services revenue up 39% YoY with internal shop visit revenue +35% and spare parts +25%; equipment revenue +20%.
• ·CES orders +93% YoY with services +49% and equipment more than tripling.
• ·DPT orders +67% YoY; defense & systems revenue +14% with deliveries +24%; propulsion & additive technologies revenue +29%.
• ·Engine deliveries increased 43% YoY; material input from priority suppliers up double-digits sequentially.
• ·Full-year 2026 CES guidance: revenue growth mid-teens (mid-teens services, mid-to-high-teens equipment), operating profit $9.6B-$9.9B.
• ·Full-year 2026 DPT guidance: revenue growth mid-to-high-single-digits, operating profit $1.55B-$1.65B.
• ·Q1 charges related to long-term service agreements ~$30M (including $100M reversal of prior tariff charge).

21-04-2026

OP Asset Management Ltd filed its Form 13F-HR on April 21, 2026, disclosing U.S. equity holdings as of December 31, 2025, consisting of approximately 776 positions all held with sole voting and investment discretion. Top holdings by market value include Apple Inc. at $518,692,026, Amazon.com Inc. at $289,447,817, Alphabet Inc. Cap Stk Cl A at $229,983,323, Alphabet Inc. Cap Stk Cl C at $226,211,832, and Broadcom Inc. at $214,466,747. No prior period comparisons or performance changes are provided in the filing.

• ·Filing period end date: December 31, 2025
• ·All positions reported as SH SOLE with 0 other managers and 0 performance row
• ·Filer CIK: 0002097005, based in Helsinki, Finland

21-04-2026

Northrop Grumman reported first quarter 2026 sales of $9,881 million, up 4% YoY from $9,468 million (5% organic growth), driven by 17% growth in Aeronautics Systems, with operating income surging 73% to $989 million (10.0% margin rate) and diluted EPS rising 85% to $6.14, alongside net awards of $9.8 billion and backlog of $95.6 billion. The company reached agreements with the U.S. Air Force to increase B-21 production and accelerate Sentinel IOC, reaffirming full-year 2026 guidance. However, Space Systems sales declined 3% to $2,480 million with operating income down 17% due to NGI wind-down and a $71 million unfavorable EAC on GEM 63XL, while Defense Systems operating margin rate slipped to 9.7% and free cash flow remained flat at $(1,823) million.

• ·2026 full-year guidance: Sales $43,500M — $44,000M; Segment operating income $4,850M — $5,000M; MTM-adjusted EPS $27.40 — $27.90; Free cash flow $3,100M — $3,500M
• ·Q1 2026 significant awards: $0.5B F-35, $0.5B infrared countermeasures, $0.4B Triton
• ·Aeronautics Systems operating margin rate improved to 9.3% from (6.5)% due to absence of prior $477M B-21 loss provision
• ·Mission Systems operating margin rate increased to 15.1% from 12.9%
• ·Space Systems $71M unfavorable EAC adjustment on GEM 63XL due to launch anomaly

21-04-2026

Atlantic Union Bankshares reported Q1 2026 net income available to common shareholders of $119.2 million ($0.84 basic/diluted EPS) and adjusted operating earnings of $126.2 million ($0.89 adjusted diluted EPS), reflecting solid execution post-Sandy Spring integration. While net interest income declined $17.8 million QoQ to $312.4 million with NIM down 10 bps to 3.80%, loans grew 2.19% QoQ and 51.65% YoY to $27,946 million, and total assets increased 51.49% YoY to $37,315 million despite a 2.92% QoQ drop. Asset quality strengthened with NPAs at 0.36% of LHFI (down 6 bps QoQ), though noninterest income fell $2.2 million QoQ and noninterest expense decreased $33.4 million mainly due to lower merger costs.

• ·Provision for credit losses $2.7 million in Q1 2026, down from $17.6 million in Q1 2025.
• ·Common equity Tier 1 capital ratio 10.21% at Q1 2026 (up from 10.10% in Q4 2025).
• ·Net charge-offs $1.6 million (0.02% annualized) in Q1 2026, up from $0.916 million in Q4 2025.
• ·Past due loans accruing 0.45% of LHFI at Q1 2026, up 4 bps QoQ.

21-04-2026

Employees Provident Fund Board disclosed its U.S. equity portfolio as of December 31, 2012, in a 13F-HR filing, reporting a total value of $1,979,124,882 across 41 holdings, all with sole voting authority. Top positions include Apple Inc ($173,500,199, 325,498 shares), Microsoft Corp ($138,813,568, 5,193,175 shares), Exxon Mobil Corp ($129,667,479, 1,498,180 shares), Procter & Gamble Co ($86,659,005, 1,276,462 shares), and Chevron Corp ($94,206,161, 871,150 shares). No period-over-period comparisons, performance data, or changes from prior filings are provided.

• ·Filing date: April 21, 2026
• ·Report period end: December 31, 2012
• ·All holdings reported with sole voting authority (SOLE)
• ·No put/call options, rights, warrants, or other manager holdings disclosed

21-04-2026

3M reported Q1 2026 GAAP net sales of $6.0 billion, up 1.3% YoY, but with organic sales down 1.4% YoY; adjusted sales showed 3.9% total growth and 1.2% organic growth YoY. GAAP EPS declined 40% to $1.23 while adjusted EPS increased 14% to $2.14, with GAAP operating margin expanding 230 bps to 23.2% but adjusted margin up only 30 bps to 23.8%. Operating cash flow was $0.6 billion, adjusted free cash flow $0.5 billion, and the company returned $2.4 billion to shareholders while reiterating FY2026 guidance for ~4% adjusted sales growth.

• ·Safety and Industrial segment organic sales up 3.2% YoY, total sales up 6.8% YoY to $2,930 million.
• ·Transportation and Electronics segment organic sales down 0.3% YoY, total sales up 1.8% YoY to $1,848 million.
• ·Consumer segment organic sales down 1.3% YoY, total sales up 0.6% YoY to $1,131 million.
• ·Cash and cash equivalents decreased to $3,729 million from $5,235 million at year-end 2025.
• ·FY2026 guidance: adjusted total sales growth ~4%, adjusted organic ~3%, adjusted operating margin expansion 70-80 bps, adjusted EPS $8.50-$8.70.

21-04-2026

RTX reported Q1 2026 sales of $22.1 billion, up 9% YoY (10% organically), with adjusted EPS of $1.78, up 21% YoY, and free cash flow of $1.3 billion, up 65% YoY, driven by growth across all segments including Collins Aerospace (+5% sales), Pratt & Whitney (+11% sales), and Raytheon (+10% sales). While all segments showed operating profit growth, Pratt & Whitney experienced a 1% decline in commercial OE sales and Collins Aerospace faced unfavorable mix and higher tariffs. The company raised its full-year 2026 outlook for adjusted sales to $92.5-$93.5 billion (previously $92.0-$93.0 billion) and adjusted EPS to $6.70-$6.90 (previously $6.60-$6.80), confirming free cash flow of $8.25-$8.75 billion.

• ·Collins Aerospace commercial OE up 15% YoY, commercial aftermarket up 7% YoY, defense up 9% YoY.
• ·Pratt & Whitney commercial aftermarket up 19% YoY, military up 7% YoY.
• ·Raytheon growth driven by land/air defense systems (Patriot, GEM-T) and naval munitions.
• ·Q1 2026 conference call held April 21, 2026 at 8:30 a.m. ET.

21-04-2026

Genprex, Inc. announced a new Sponsored Research Agreement with The University of Texas MD Anderson Cancer Center to study TROP2 and PTEN biomarkers potentially predicting response to Reqorsa® Gene Therapy (quaratusugene ozeplasmid) for NSCLC and SCLC, aiming to refine patient selection in Acclaim-1 and Acclaim-3 trials. Updates on Acclaim-1 (with AstraZeneca’s Tagrisso®) and Acclaim-3 (with Genentech’s Tecentriq®) indicate Phase 1 dose escalations completed with no dose-limiting toxicities and early efficacy signals including prolonged PFS and partial responses in some patients. An investor presentation is available on the company’s website.

• ·Acclaim-1 Phase 1 showed REQORSA generally well tolerated despite doubling starting dose; one patient continues treatment after 60 courses (~42 months).
• ·Acclaim-3 Phase 1: one patient continues study treatment after unconfirmed partial remission post-24 cycles and >18 months.
• ·Genprex enrolling/treating patients in Phase 2a expansion of Acclaim-1 and Phase 2 expansion of Acclaim-3.